On the pathogenesis of diabetic retinopathy. A 1990 update

Area of Science:

• Ophthalmology
• Endocrinology
• Molecular Biology

Background:

• Diabetic retinopathy is a leading cause of vision loss.
• Chronic hyperglycemia is widely suspected as the primary cause of diabetic retinopathy and other diabetes complications.
• The precise molecular mechanisms underlying diabetic retinopathy remain incompletely understood.

Purpose of the Study:

• To review the evidence linking chronic hyperglycemia to diabetic retinopathy.
• To explore potential mechanisms, including aldose reductase activity, nonenzymatic glycation, and growth factor involvement.
• To assess the current state of knowledge regarding therapeutic interventions.

Main Methods:

• Literature review of studies on diabetic retinopathy pathogenesis.
• Analysis of research on aldose reductase inhibition and nonenzymatic glycation.
• Examination of findings related to growth factors (e.g., fibroblast growth factors, transforming growth factor-beta) and inhibitors in retinal neovascularization.

Main Results:

• While chronic hyperglycemia is implicated, definitive proof is lacking.
• Aldose reductase's role is debated, with negative human trial results for inhibitors.
• Nonenzymatic glycation lacks direct causal evidence in diabetic retinopathy.
• Growth factors like FGFs may promote, while TGF-beta and basement membrane inhibit, retinal neovascularization.

Conclusions:

• The exact pathogenic pathways of diabetic retinopathy are complex and multifactorial.
• Further research is needed to elucidate the precise role of hyperglycemia and identify effective therapeutic targets.
• Understanding the balance of pro- and anti-angiogenic factors is crucial for developing treatments.